The Next Credible AI Course May Be About Policy, Not Prompting
Earlier coverage of learning design and its implications for CME providers.
Shorter live blocks, replay access, and micro-format CME are being marketed as easier commitments, though the evidence still reflects supply-side positioning more than proven clinician demand.
This week’s clearest public theme is that CME offers are being framed as easier commitments. The evidence leans heavily on provider, society, and institutional sources, so the right read is packaging pressure rather than verified clinician demand.
Across conference and digital channels, shorter attendance windows, replay access, and modular formats were presented as part of the reason to engage, not just as logistics. A CME-oriented podcast promotion highlighted half-day meetings and flexible online options as schedule-friendly (The Curbsiders). A society-linked oncology format used explicit microlearning structuring around conference review (Oncology Today), with replayable digital distribution visible in companion video publishing (Research To Practice).
That does not prove clinicians now prefer shorter formats in general, and this week’s evidence is largely promotional. But it does show a change in positioning. The offer is no longer only "good content"; it is also "this will not take over your schedule." That is distinct from earlier discussions about instructional chunking or workflow fit, including our prior brief on when clinical guidance outpaces static course formats.
For CME providers, the question is not whether every activity should get shorter. It is whether your portfolio still assumes attendance commitments that are getting harder to defend when competitors are explicitly selling bounded time, replayability, and modular access.
This week’s AI discussion did not center on broad capability claims. Instead, the more credible examples described support roles: screening literature, assisting document review, reducing administrative burden, flagging patients, and helping with workflow while keeping expert adjudication in place. The clearest governance-heavy example came from an FDA Grand Rounds session on LLMs in regulatory review, which emphasized context of use, data quality, benchmarking, sensitive-data handling, and expert review loops (FDA Grand Rounds). An oncology and palliative care conversation made the same point in plainer clinical terms: AI may help with support tasks, but not replace judgment (Oncology On The Go).
This is best read as a continuity update, not a new AI lead. As in an earlier brief on supervised delegation in AI education, credibility rises when the tool’s role is specific and the human checkpoint is visible.
For providers still publishing AI education, broad literacy overviews are a weaker fit than cases that define the task boundary, show where review happens, and teach what counts as acceptable supervision.
Earlier coverage of learning design and its implications for CME providers.
Earlier coverage of learning design and its implications for CME providers.
Earlier coverage of learning design and its implications for CME providers.
ChatCME surfaces the questions clinicians actually ask — so you can build activities that close real knowledge gaps.
Request a demo